Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Advisor to its Board and Chair of its R and D Committee
Read Article
News
2024
2023
Archive
Search news articles
June 15, 2010
WOMEN’S HEALTH COMPANY VIVEVE SPONSORS AWARD WINNING ABSTRACT AT ACOG
June 8, 2010
IKARIA® APPOINTS CHIEF MEDICAL OFFICER
June 5, 2010
SEMPRUS BIOSCIENCES SELECTED AS ONE OF THE “50 COMPANIES TO WATCH” IN MD+DI JUNE ISSUE
June 1, 2010
IKARIA® NAMES NEW HEAD OF RESEARCH & DEVELOPMENT
May 5, 2010
PEARL THERAPEUTICS’ BRONCHODILATOR COMBINATION THERAPEUTIC FOR COPD TO BE PRESENTED AT THE AMERICAN THORACIC SOCIETY ANNUAL MEETING
April 14, 2010
SYNOSIA THERAPEUTICS’ SYN-115 IMPROVES MOTOR AND NON-MOTOR FUNCTION IN PATIENTS WITH MILD-TO-MODERATE PARKINSON’S DISEASE
April 7, 2010
ACHAOGEN COMPLETES $56 MILLION SERIES C FINANCING
March 30, 2010
IKARIA® ACQUIRES NEW DRUG APPLICATION FOR LUCASSIN®
March 29, 2010
PEARL THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM PHASE 1 TRIAL OF PT003, A BRONCHODILATOR COMBINATION THERAPEUTIC FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE, AND INITIATION OF PHASE 2B TRIAL
February 17, 2010
MARCADIA INITIATES PHASE I CLINICAL TRIAL OF GLP-1/GIP DUAL AGONIST MAR701
« Previous Page
1
…
98
99
100
101
102
103